Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies

Immunology

Volumn 128, Issue 2, 2009, Pages 172-184

  David, Gaëlle ^a   Morvan, Maelig ^a   Gagne, Katia ^a   Kerdudou, Nolwenn ^a   Willem, Catherine ^a   Devys, Anne ^a   Bonneville, Marc ^b   Folléa, Gilles ^a   Bignon, Jean Denis ^a   Retière, Christelle ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b Team 12   (France)

Author keywords

Killer cell immunoglobulin like receptor (KIR) genotype; KIR; KIR2DL1; KIR2DL2; KIR2DS1; Monoclonal antibody; Natural killer cells

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1F12; MONOCLONAL ANTIBODY 8C11; MONOCLONAL ANTIBODY EB6; MONOCLONAL ANTIBODY GL183; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; IMMUNIZATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR CLONING; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BASE SEQUENCE; GENOTYPE; HUMANS; HYBRIDOMAS; IMMUNIZATION; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3; SEQUENCE ALIGNMENT;

EID: 69949133040     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03085.x     Document Type: Article

References (34)

1. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004 4 : 190 198.
2. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005 5 : 201 214.
3. + T cells. Blood 2008 112 : 2381 2389.
4. + T cells in human immunodeficiency virus type 1 infection. J Virol 2008 82 : 9668 9677.
5. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995 2 : 439 449.
6. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002 54 : 221 229.
7. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004 16 : 626 633.
8. Stern M, Ruggeri L, Capanni M, Mancusi A, Velardi A. Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. Blood 2008 112 : 708 710.
9. Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, Bowness P. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002 46 : 2972 2982.
10. Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, McMichael A, Bowness P. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007 37 : 1313 1322.
11. Hou LH, Steiner NK, Chen M, Belle I, Ng J, Hurley CK. KIR2DL1 allelic diversity: Four new alleles characterized in a bone marrow transplant population and three families. Tissue Antigens 2007 69 : 250 254.
12. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995 182 : 875 884.
13. Stewart CA, Laugier-Anfossi F, Vely F et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005 102 : 13224 13229.
14. Saulquin X, Gastinel LN, Vivier E. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J Exp Med 2003 197 : 933 938.
15. Loirat MJ, Gourbil A, Frioux Y, Muller JY, Blanchard D. A murine monoclonal antibody directed against the Gerbich 3 blood group antigen. Vox Sang 1992 62 : 45 8.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 16 : 1215.
17. Marsh SG, Parham P, Dupont B et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 2003 62 : 79 86.
18. Denis L, Sivula J, Gourraud PA et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 2005 66 : 267 276.
19. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002 168 : 2307 2315.
20. Gagne K, Brizard G, Gueglio B et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002 63 : 271 280.
21. Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol 2007 179 : 854 868.
22. Foley B, De Santis D, Lathbury L, Christiansen F, Witt C. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol 2008 4 : 555 563.
23. Morvan M, David G, Sebille V et al. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur J Immunol 2008 38 : 3474 3486.
24. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006 203 : 633 645.
25. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 2008 180 : 3969 3979.
26. Meenagh A, Gonzalez A, Sleator C, McQuaid S, Middleton D. Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1. Tissue Antigens 2008 4 : 383 391.
27. Sharkey AM, Gardner L, Hiby S et al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J Immunol 2008 181 : 39 46.
28. Trowsdale J, Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol 2008 6 : 317 320.
29. van Bergen J, Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 2004 173 : 6719 6726.
30. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001 193 : 1159 1167.
31. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 2003 93 : 106 113.
32. + T lymphocytes. J Immunol 2008 180 : 2767 2771.
33. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 2007 149 : 1 8.
34. Vivier E, Romagne F. Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion. Immunity 2007 26 : 549 551.